This morning someone was feeling confident enough about this company to invest $2 and 2.88 cents and raise its share price by a tenth of a cent.Could it be a turnaround?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%